- Home
- AROC vs PTGX Comparison
AROC vs PTGX Comparison
Compare AROC & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AROC
- PTGX
- Stock Information
- Founded
- AROC 1990
- PTGX 2006
- Country
- AROC United States
- PTGX United States
- Employees
- AROC N/A
- PTGX N/A
- Industry
- AROC Oil & Gas Production
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- AROC Energy
- PTGX Health Care
- Exchange
- AROC Nasdaq
- PTGX Nasdaq
- Market Cap
- AROC 4.2B
- PTGX 3.7B
- IPO Year
- AROC 1997
- PTGX 2016
- Fundamental
- Price
- AROC $24.41
- PTGX $58.86
- Analyst Decision
- AROC Buy
- PTGX Strong Buy
- Analyst Count
- AROC 6
- PTGX 9
- Target Price
- AROC $30.00
- PTGX $70.44
- AVG Volume (30 Days)
- AROC 1.4M
- PTGX 880.7K
- Earning Date
- AROC 11-10-2025
- PTGX 11-06-2025
- Dividend Yield
- AROC 3.41%
- PTGX N/A
- EPS Growth
- AROC 49.93
- PTGX N/A
- EPS
- AROC 1.33
- PTGX 0.80
- Revenue
- AROC $1,348,892,000.00
- PTGX $209,180,000.00
- Revenue This Year
- AROC $31.31
- PTGX N/A
- Revenue Next Year
- AROC $6.91
- PTGX $185.11
- P/E Ratio
- AROC $18.53
- PTGX $73.51
- Revenue Growth
- AROC 28.23
- PTGX N/A
- 52 Week Low
- AROC $18.97
- PTGX $33.31
- 52 Week High
- AROC $30.44
- PTGX $61.89
- Technical
- Relative Strength Index (RSI)
- AROC 50.40
- PTGX 54.53
- Support Level
- AROC $24.01
- PTGX $54.50
- Resistance Level
- AROC $25.61
- PTGX $61.04
- Average True Range (ATR)
- AROC 0.63
- PTGX 2.72
- MACD
- AROC -0.06
- PTGX -0.07
- Stochastic Oscillator
- AROC 30.23
- PTGX 59.00
About AROC Archrock Inc.
Archrock Inc is an energy infrastructure company with a focus on midstream natural gas compression and a commitment to helping customers produce, compress, and transport natural gas. It has two business segments, Contract Operations, and Aftermarket Services. Under the umbrella of contract operations services, the company provides operations to meet customers' natural gas compression needs. Services include designing, owning, installing, operating, and maintaining equipment. Aftermarket Services business provides a full range of services to support the compression needs of customers who own compression equipment, including operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components. It generates maximum revenue from the Contract Operations segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.